Unmasking hidden risks: cerebral venous sinus thrombosis and spontaneous subdural hematoma in women on oral contraceptives - insights from a case report and systematic literature review.

Case report Cerebral venous sinus thrombosis Estrogen-progestin treatment Pills Subdural hematoma

Journal

Neuro-Chirurgie
ISSN: 1773-0619
Titre abrégé: Neurochirurgie
Pays: France
ID NLM: 0401057

Informations de publication

Date de publication:
09 Oct 2024
Historique:
received: 19 06 2024
revised: 18 08 2024
accepted: 03 09 2024
medline: 11 10 2024
pubmed: 11 10 2024
entrez: 10 10 2024
Statut: aheadofprint

Résumé

Cerebral venous thrombosis (CVT) is a rare but critical condition, particularly in young women, often linked to oral contraceptive use. It can lead to complications like subdural hematoma (SH), which are challenging to diagnose and manage. We report the case of a 39-year-old woman who presented with severe headaches and neurological symptoms, leading to a diagnosis of chronic SH and CVT, associated with long-term oral contraceptive use. This case is unique as it documents the first known instance of chronic SH associated with CVT induced by oral contraceptives. Our objective was to explore this association using the Bradford Hill criteria and to review the diagnostic and therapeutic challenges of CVT and SH in this population. We conducted a systematic literature review adhering to PRISMA guidelines, focusing on SH cases linked to CVT in women using oral contraceptives. Including our case, four cases of SH associated with CVT secondary to oral contraceptive use were identified. Common symptoms included severe headache and neurological deficits. All patients received anticoagulation therapy, with surgical intervention required in severe cases. Prognosis was generally favorable with appropriate management. This case emphasizes the importance of considering CVT in women presenting with spontaneous SH, particularly those on oral contraceptives. Early diagnosis, careful clinical and radiological monitoring, and timely surgical intervention are crucial for optimal outcomes.

Sections du résumé

BACKGROUND AND OBJECTIVE OBJECTIVE
Cerebral venous thrombosis (CVT) is a rare but critical condition, particularly in young women, often linked to oral contraceptive use. It can lead to complications like subdural hematoma (SH), which are challenging to diagnose and manage. We report the case of a 39-year-old woman who presented with severe headaches and neurological symptoms, leading to a diagnosis of chronic SH and CVT, associated with long-term oral contraceptive use. This case is unique as it documents the first known instance of chronic SH associated with CVT induced by oral contraceptives. Our objective was to explore this association using the Bradford Hill criteria and to review the diagnostic and therapeutic challenges of CVT and SH in this population.
METHODS METHODS
We conducted a systematic literature review adhering to PRISMA guidelines, focusing on SH cases linked to CVT in women using oral contraceptives.
RESULTS RESULTS
Including our case, four cases of SH associated with CVT secondary to oral contraceptive use were identified. Common symptoms included severe headache and neurological deficits. All patients received anticoagulation therapy, with surgical intervention required in severe cases. Prognosis was generally favorable with appropriate management.
CONCLUSION CONCLUSIONS
This case emphasizes the importance of considering CVT in women presenting with spontaneous SH, particularly those on oral contraceptives. Early diagnosis, careful clinical and radiological monitoring, and timely surgical intervention are crucial for optimal outcomes.

Identifiants

pubmed: 39388782
pii: S0028-3770(24)00074-2
doi: 10.1016/j.neuchi.2024.101603
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

101603

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Auteurs

Marta Arrighi (M)

Service de Neurochirurgie, CHU Clermont-Ferrand, Clermont-Ferrand, F-63000, France; INSERM, CIC 1405, Unité CRECHE, Clermont-Ferrand, F-63000, France.

Quentin Berton (Q)

Service de Neurochirurgie, CHU Clermont-Ferrand, Clermont-Ferrand, F-63000, France; INSERM, CIC 1405, Unité CRECHE, Clermont-Ferrand, F-63000, France.

Emmanuel de Schlichting (E)

Service de Neurochirurgie, Centre Hospitalier Universitaire de Grenoble-Alpes, Université de Grenoble Alpes, Grenoble, France.

Djene Ibrahima Kaba (DI)

Service de Neurochirurgie, CHU Clermont-Ferrand, Clermont-Ferrand, F-63000, France.

Paul Roblot (P)

Service de Neurochirurgie A, Hôpital Pellegrin, CHU Bordeaux, F-33000, France.

Guillaume Coll (G)

Service de Neurochirurgie, CHU Clermont-Ferrand, Clermont-Ferrand, F-63000, France; INSERM, CIC 1405, Unité CRECHE, Clermont-Ferrand, F-63000, France. Electronic address: gcoll@chu-clermontferrand.fr.

Classifications MeSH